Trial record 5 of 98 for:    Open Studies | "Mouth Neoplasms"

Expression of VEGF-C and VEGF-CR in Oral Cancers and Premalignant Lesions

The recruitment status of this study is unknown because the information has not been verified recently.
Verified August 2004 by National Taiwan University Hospital.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
National Taiwan University Hospital
ClinicalTrials.gov Identifier:
NCT00173316
First received: September 12, 2005
Last updated: NA
Last verified: August 2004
History: No changes posted
  Purpose

The role of vascular endothelial growth factor-C (VEGF-C) and its receptors induced lymphangiogenesis and host inflammatory responses on the carcinogenesis of oral cancers and premalignant lesions


Condition
Oral Cancer

Study Type: Observational
Study Design: Observational Model: Defined Population
Primary Purpose: Screening
Time Perspective: Longitudinal
Official Title: The Role of Vascular Endothelial Growth Factor-C (VEGF-C) and Its Receptors Induced Lymphangiogenesis on the Carcinogenesis of Oral Cancers and Premalignant Lesions

Resource links provided by NLM:


Further study details as provided by National Taiwan University Hospital:

Estimated Enrollment: 80
Study Start Date: August 2004
Estimated Study Completion Date: June 2005
Detailed Description:

The role of vascular endothelial growth factor-C (VEGF-C) and its receptors induced lymphangiogenesis and host inflammatory responses on the carcinogenesis of oral cancers and premalignant lesions

  Eligibility

Ages Eligible for Study:   18 Years to 85 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • oral cancer and oral precancer specimens

Exclusion Criteria:

  • other diseases
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00173316

Contacts
Contact: Chun-Pin Chiang, DMSc 886-2-23123456 ext 6855 cpchiang@ha.mc.ntu.edu.tw

Locations
Taiwan
National Taiwan university Recruiting
Taipei, Taiwan, 100
Principal Investigator: Chun-Pin Chiang, DMSc         
Sponsors and Collaborators
National Taiwan University Hospital
Investigators
Principal Investigator: Chun-Pin Chiang, DMSc National Taiwan University
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00173316     History of Changes
Other Study ID Numbers: 9461700614
Study First Received: September 12, 2005
Last Updated: September 12, 2005
Health Authority: Taiwan: Department of Health

Keywords provided by National Taiwan University Hospital:
vascular endothelial growth factor-C
VEGF-CR
lymphangiogenesis
host inflammatory responses
oral carcinogenesis
oral cancers
oral premalignant lesions

Additional relevant MeSH terms:
Mouth Neoplasms
Lip Neoplasms
Precancerous Conditions
Head and Neck Neoplasms
Neoplasms by Site
Neoplasms
Mouth Diseases
Stomatognathic Diseases
Lip Diseases
Mitogens
Endothelial Growth Factors
Mitosis Modulators
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Growth Substances
Physiological Effects of Drugs

ClinicalTrials.gov processed this record on April 17, 2014